Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION

Filed by CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 6, 2025
Income
$10,000.00
Expenses
Not reported
Filing UUID
79c9fdf6-e2dc-4675-8e20-94f4ffa98019
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

Hereditary Hemorrhagic Telanglectasia (HHT)

HCR · Health Issues

HR 4016/S 2572, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); HR 5304/S 2587, FY26 Labor HHS Education Appropriations Act, National HHT Center of Excellence Program

Literal federal measure citations: HR 4016, S 2572, HR 5304, S 2587

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.